Home » Authors » James Etheridge

Articles by James Etheridge

Immutep Initiating Phase I IMP321 Breast Cancer Trial

Aug. 9, 2006

By James Etheridge

Immutep Initiating Phase I IMP321 Breast Cancer Trial

Aug. 9, 2006

By James Etheridge

NicOx To Initiate Two Phase II Trials Of NCX 4016 In Diabetes

Aug. 2, 2006

By James Etheridge

NicOx To Initiate Two Phase II Trials Of NCX 4016 In Diabetes

Aug. 2, 2006

By James Etheridge

Cellectis, Lexicon Genetics Exchange Rights To Patents

July 19, 2006

By James Etheridge

Cellectis, Lexicon Genetics Exchange Rights To Patents

July 19, 2006

By James Etheridge

LTKfarma Setting Up Shop With Product In Phase I/II

July 12, 2006

By James Etheridge

Eurofins Scientific Invests In Danish, Japanese Food Firms

July 12, 2006

By James Etheridge

Eurofins Scientific Invests In Danish, Japanese Food Firms

July 12, 2006

By James Etheridge

LTKfarma Setting Up Shop With Product In Phase I/II

July 12, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...